Tanshinone II Aattenuates renal damage in STZ-induced diabetic rats via inhibiting oxidative stress and inflammation
Metrics: PDF 956 views | HTML 1455 views | ?
Xia Chen1,*, Rui Wu1,*, Yiwei Kong1,*, Yuting Yang1,*, Yu Gao1, Dandan Sun1, Qizhen Liu1, Dongjun Dai1, Zeyuan Lu1, Niansong Wang1, Sheng Ge3, Feng Wang1,2
1Department of Nephrology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, China
2Department of Nephrology, Shanghai Eighth People’s Hospital, Shanghai 200233, China
3Department of Clinical Nutrition, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, China
*These authors contributed equally to this work
Sheng Ge, email: firstname.lastname@example.org
Feng Wang, email: email@example.com
Keywords: tanshinone, kidney, diabetes
Received: January 25, 2017 Accepted: March 02, 2017 Published: March 29, 2017
Oxidative stress and inflammation have been demonstrated to be involved in the onset and promotion of diabetic nephropathy (DN).Tanshinone IIA (Tan) possesses both antioxidant and anti-inflammatory properties. Here, the aim of the present study was to explore whether Tan could attenuate renal damage in the rats with streptozotocin (STZ)-induced diabetes and its potential mechanisms. Tan was gavaged to STZ-induced diabetic rats at the dose of 10mg/kg once a day for 12 weeks. Tan treatment significantly attenuated albuminuria and renal histopathology in diabetic rats. Besides, Tan treatment also effectively inhibited oxidative stress and inflammatory reaction in the kidneys of diabetic rats. Our study provided evidence that the protective effect of Tan on diabetes-induced renal injury is associated with inhibition of oxidative stress and inflammation. Tan may be a potential candidate for the treatment of DN.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.